Not applicableWithdrawnNCT05846165What this trial is testingInveStigAting Bladder fiELd-cycLing imAgingWho this might be right forBladder Cancer University of Aberdeen
Not applicableNot Yet RecruitingNCT06675656What this trial is testingPredictive Role of Microbiome in Patients With Urothelial CarcinomaWho this might be right forUrinary Bladder Cancer IRCCS San Raffaele 420
Testing effectiveness (Phase 2)Looking for participantsNCT07030257What this trial is testingStudy of CP-383 in Patients With Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor MalignanciesColorectal CarcinomaSmall Cell Lung Cancer ( SCLC )+4 more Tasca Therapeutics 150
Not applicableLooking for participantsNCT05415631What this trial is testingAugmented Bladder Tumor Detection Using Real Time Based Artificial IntelligenceWho this might be right forBladder CancerCystoscopyArtificial Intelligence Centre Hospitalier Universitaire, Amiens 500
Early research (Phase 1)Active Not RecruitingNCT06253845What this trial is testingStudy of CG0070 After Transurethral Resection in Patients With IR NMIBCWho this might be right forNon-muscle Invasive Bladder Cancer H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Not applicableUnknownNCT05844059What this trial is testingLower Urinary Tract Symptoms After Intravesical TherapyWho this might be right forChemotherapy EffectChemotherapeutic ToxicityLower Urinary Tract Symptoms+1 more Ludwig-Maximilians - University of Munich 60
Testing effectiveness (Phase 2)Looking for participantsNCT05592626What this trial is testingA Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more Marengo Therapeutics, Inc. 366
Testing effectiveness (Phase 2)Study completedNCT02581982What this trial is testingPaclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial CancerWho this might be right forTransitional Cell Carcinoma Wake Forest University Health Sciences 27
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Not applicableNot Yet RecruitingNCT07762820What this trial is testingREtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder TumorsWho this might be right forBladder CancerBladder Cancer TNM Staging Primary Tumor (T) T1 Ludwig-Maximilians - University of Munich 75
Testing effectiveness (Phase 2)Study completedNCT00088946What this trial is testingErlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder CancerWho this might be right forBladder Cancer Jonsson Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Ended earlyNCT01094496What this trial is testingThe CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)Who this might be right forBladder Cancer Celldex Therapeutics 3
Not applicableLooking for participantsNCT06218433What this trial is testingUrothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)Who this might be right forUrothelial CarcinomaLynch Syndrome Tampere University Hospital 200
Testing effectiveness (Phase 2)UnknownNCT03824691What this trial is testingHARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"Who this might be right forBladder Carcinoma Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 122
Post-approval studies (Phase 4)Study completedNCT00666978What this trial is testingHealth Education Counseling With or Without Bupropion in Helping African Americans Stop SmokingWho this might be right forBladder CancerCervical CancerEsophageal Cancer+8 more Lisa Sanderson Cox, PhD 540
Large-scale testing (Phase 3)UnknownNCT02948543What this trial is testingAdding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder CancerWho this might be right forBladder Cancer University of Sydney 501
Not applicableStudy completedNCT03064308What this trial is testingThe Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major SurgeryWho this might be right forImpaired CognitionQuality of LifeSurgery+7 more University of Nottingham 11
Early research (Phase 1)Looking for participantsNCT05562791What this trial is testing68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerWho this might be right forBladder Cancer Memorial Sloan Kettering Cancer Center 20
Early research (Phase 1)Study completedNCT00019435What this trial is testingLMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+4 more National Cancer Institute (NCI)